MX2019000384A - Metodo para producir una forma polimorfica de 3-[5-amino-4-(3-cianobenzoilo)-pirazol-1-il]-n-ciclopropil-4-meti lbenzamida. - Google Patents
Metodo para producir una forma polimorfica de 3-[5-amino-4-(3-cianobenzoilo)-pirazol-1-il]-n-ciclopropil-4-meti lbenzamida.Info
- Publication number
- MX2019000384A MX2019000384A MX2019000384A MX2019000384A MX2019000384A MX 2019000384 A MX2019000384 A MX 2019000384A MX 2019000384 A MX2019000384 A MX 2019000384A MX 2019000384 A MX2019000384 A MX 2019000384A MX 2019000384 A MX2019000384 A MX 2019000384A
- Authority
- MX
- Mexico
- Prior art keywords
- methylbenzamide
- pyrazol
- cyclopropyl
- amino
- cyanob
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Esta invención se refiere a un proceso para la preparación de la Forma B de 3-[5-amino-4-(3-cianobenzoil)pirazol-1-iI]-N-ciclopropi l-4-metilbenzamida. En la presente también se describe la Forma B de 3-[5-amino-4-(3-cianobenzoil)-pirazol-1-il]-N-ciclopropil-4-met ilbenzamida, o composiciones farmacéuticas de la misma, que se pueden obtener mediante el procedimiento descrito en la presente.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1612238.4A GB201612238D0 (en) | 2016-07-14 | 2016-07-14 | Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-Yl]-n-cyclopropyl-4-methylbenzamide |
| PCT/GB2017/052055 WO2018011578A1 (en) | 2016-07-14 | 2017-07-13 | Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2019000384A true MX2019000384A (es) | 2019-05-23 |
Family
ID=56890595
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019000384A MX2019000384A (es) | 2016-07-14 | 2017-07-13 | Metodo para producir una forma polimorfica de 3-[5-amino-4-(3-cianobenzoilo)-pirazol-1-il]-n-ciclopropil-4-meti lbenzamida. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US10995071B2 (es) |
| EP (1) | EP3484853B9 (es) |
| JP (1) | JP7094020B2 (es) |
| KR (1) | KR102460533B1 (es) |
| CN (1) | CN109415325B (es) |
| AU (1) | AU2017294642B2 (es) |
| BR (1) | BR112019000540A2 (es) |
| CA (1) | CA3030617C (es) |
| DK (1) | DK3484853T5 (es) |
| ES (1) | ES2879608T3 (es) |
| GB (1) | GB201612238D0 (es) |
| HU (1) | HUE054686T2 (es) |
| IL (1) | IL263900B (es) |
| MX (1) | MX2019000384A (es) |
| PL (1) | PL3484853T3 (es) |
| PT (1) | PT3484853T (es) |
| RU (1) | RU2765719C2 (es) |
| SG (1) | SG11201811517SA (es) |
| WO (1) | WO2018011578A1 (es) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE292118T1 (de) * | 1998-05-05 | 2005-04-15 | Hoffmann La Roche | Pyrazolderivative als p-38 map kinase inhibitoren |
| AU2004259662B2 (en) * | 2003-06-26 | 2008-08-07 | Mereo Biopharma 1 Limited | 5-membered heterocycle-based p38 kinase inhibitors |
| KR101793777B1 (ko) | 2012-03-20 | 2017-11-03 | 노파르티스 아게 | 만성 폐쇄성 폐 질환의 급성 악화의 치료에서의 피라졸 유도체의 용도 |
| MX2018010782A (es) | 2016-03-08 | 2019-01-10 | Mereo Biopharma 1 Ltd | Regimen de dosificacion para el tratamiento de exacerbaciones agudas de enfermedad pulmonar obstructiva cronica. |
| AU2016397046B2 (en) | 2016-03-08 | 2022-05-12 | Mereo Biopharma 1 Limited | Dosage regimen for the treatment of acute exacerbations of inflammatory conditions |
-
2016
- 2016-07-14 GB GBGB1612238.4A patent/GB201612238D0/en not_active Ceased
-
2017
- 2017-07-13 EP EP17742277.1A patent/EP3484853B9/en active Active
- 2017-07-13 AU AU2017294642A patent/AU2017294642B2/en active Active
- 2017-07-13 CN CN201780041115.7A patent/CN109415325B/zh active Active
- 2017-07-13 SG SG11201811517SA patent/SG11201811517SA/en unknown
- 2017-07-13 JP JP2019501449A patent/JP7094020B2/ja active Active
- 2017-07-13 US US16/317,014 patent/US10995071B2/en active Active
- 2017-07-13 CA CA3030617A patent/CA3030617C/en active Active
- 2017-07-13 BR BR112019000540-4A patent/BR112019000540A2/pt active Search and Examination
- 2017-07-13 DK DK17742277.1T patent/DK3484853T5/da active
- 2017-07-13 PT PT177422771T patent/PT3484853T/pt unknown
- 2017-07-13 KR KR1020197001013A patent/KR102460533B1/ko active IP Right Grant
- 2017-07-13 RU RU2019103879A patent/RU2765719C2/ru active
- 2017-07-13 HU HUE17742277A patent/HUE054686T2/hu unknown
- 2017-07-13 ES ES17742277T patent/ES2879608T3/es active Active
- 2017-07-13 MX MX2019000384A patent/MX2019000384A/es unknown
- 2017-07-13 WO PCT/GB2017/052055 patent/WO2018011578A1/en unknown
- 2017-07-13 PL PL17742277T patent/PL3484853T3/pl unknown
-
2018
- 2018-12-23 IL IL263900A patent/IL263900B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUE054686T2 (hu) | 2021-09-28 |
| PL3484853T3 (pl) | 2021-11-02 |
| US20190315694A1 (en) | 2019-10-17 |
| SG11201811517SA (en) | 2019-01-30 |
| EP3484853A1 (en) | 2019-05-22 |
| CA3030617A1 (en) | 2018-01-18 |
| KR102460533B1 (ko) | 2022-10-31 |
| AU2017294642B2 (en) | 2021-03-04 |
| BR112019000540A2 (pt) | 2019-04-24 |
| CN109415325A (zh) | 2019-03-01 |
| CA3030617C (en) | 2024-02-20 |
| JP7094020B2 (ja) | 2022-07-01 |
| DK3484853T5 (da) | 2021-09-06 |
| AU2017294642A1 (en) | 2019-01-17 |
| RU2765719C2 (ru) | 2022-02-02 |
| DK3484853T3 (da) | 2021-05-25 |
| EP3484853B1 (en) | 2021-04-21 |
| US10995071B2 (en) | 2021-05-04 |
| EP3484853B9 (en) | 2021-07-28 |
| CN109415325B (zh) | 2022-04-01 |
| IL263900A (en) | 2019-01-31 |
| JP2019521133A (ja) | 2019-07-25 |
| KR20190027819A (ko) | 2019-03-15 |
| ES2879608T3 (es) | 2021-11-22 |
| GB201612238D0 (en) | 2016-08-31 |
| RU2019103879A3 (es) | 2020-08-14 |
| IL263900B (en) | 2022-04-01 |
| PT3484853T (pt) | 2021-05-25 |
| RU2019103879A (ru) | 2020-08-14 |
| WO2018011578A1 (en) | 2018-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2017014351A (es) | Un proceso para la preparacion de epoxido de terpinoleno. | |
| WO2015121379A3 (en) | Process for producing vanillin | |
| SA518391776B1 (ar) | تخليق انتقائي مزدوج التجاسم لمشتقات الفوسفات | |
| MX2019000664A (es) | Preparacion de 14-metil-16-oxabiciclo[10.3.1]pentadecenos de 3-metil-1,5 ciclopentadecanediona. | |
| MX2017004739A (es) | Proceso estereoselectivo para obtener metilamidas del acido (z)-5-cicliloxi-2[(e)-metoximino]-3-metil-pent-3-enico usando mezcla de isomeros e, z e intermediarios de aquellas. | |
| MX2016013555A (es) | Produccion de 4-hidroxi-4-metil-tetrahidropiranos 2-sustituidos a partir de materiales de partida que contienen 2-alquil-4,4-dimetil-1,3-dioxanos. | |
| MX2017003301A (es) | Producto refractario, relleno para fabricar el producto, procedimiento para fabricar el producto y uso del producto refractario. | |
| MX2019004024A (es) | Metodo para preparar acetofenonas sustituidas con ciclopropilo. | |
| MX2016015465A (es) | Composicion farmaceutica oral de isotretinoina. | |
| PH12018500872A1 (en) | Innovative preparation and crystallization of iosimenol | |
| MX2021004996A (es) | Preparacion de 4-metiltetrahidropiranos 2-sustituidos a partir de 4-hidroxi-4-metiltetrahidropiranos 2-sustituidos como materiales de partida. | |
| MX2021008323A (es) | Preparacion de 5-aril pentanoles. | |
| MX2019000385A (es) | Metodo para producir una forma polimorfica de 3-[5-amino-4-(3-cianobenzoilo)-pirazol-1-il]-n-ciclopropil-4-meti lbenzamida. | |
| MX2018014918A (es) | Esteres de tetrahidropiranilalquilo inferior y su produccion usando un compuesto de ceteno. | |
| MX2019000384A (es) | Metodo para producir una forma polimorfica de 3-[5-amino-4-(3-cianobenzoilo)-pirazol-1-il]-n-ciclopropil-4-meti lbenzamida. | |
| ZA202000381B (en) | Process for making esters of 2,5-furandicarboxylic acid | |
| MX2017008776A (es) | Relleno para preparar un producto refractario, un procedimiento para preparar un producto refractario, un producto refractario, y uso de un producto refractario. | |
| MX2016016398A (es) | Preparacion de piperidin-4-carbotioamida. | |
| MX2016017019A (es) | Metodo para la preparacion de 4-alcoxi-1,1,1-trifluorobut-3-en-2-o nas de 1,1,1 trifluoroacetona. | |
| WO2015118558A3 (en) | Process for the preparation of clofarabine | |
| WO2018198101A3 (en) | Processes for the preparation of crystalline form of eluxadoline | |
| IN2014CH00444A (es) | ||
| HUP1800125A2 (en) | Process for production of iloprost | |
| IN2014MU00072A (es) | ||
| MY187078A (en) | Process of production of 7,8-dihydro-c15-aldehyde |